Huntington National Bank lowered its stake in shares of Clorox Co (NYSE:CLX) by 5.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,433 shares of the company’s stock after selling 440 shares during the period. Huntington National Bank’s holdings in Clorox were worth $1,850,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently added to or reduced their stakes in the company. State of Michigan Retirement System boosted its stake in Clorox by 10.9% during the second quarter. State of Michigan Retirement System now owns 31,903 shares of the company’s stock worth $6,999,000 after buying an additional 3,133 shares during the period. Everett Harris & Co. CA purchased a new stake in shares of Clorox during the second quarter valued at $219,000. Carl P. Sherr & Co. LLC purchased a new stake in shares of Clorox during the second quarter valued at $219,000. Eads & Heald Wealth Management boosted its stake in shares of Clorox by 0.9% during the second quarter. Eads & Heald Wealth Management now owns 6,635 shares of the company’s stock valued at $1,456,000 after purchasing an additional 60 shares during the period. Finally, Mattern Wealth Management LLC boosted its stake in shares of Clorox by 111.5% during the second quarter. Mattern Wealth Management LLC now owns 4,631 shares of the company’s stock valued at $1,016,000 after purchasing an additional 2,441 shares during the period. Hedge funds and other institutional investors own 78.55% of the company’s stock.
In related news, CAO Jeff Baker sold 5,158 shares of the stock in a transaction on Friday, May 8th. The stock was sold at an average price of $203.74, for a total value of $1,050,890.92. Following the completion of the transaction, the chief accounting officer now directly owns 7,963 shares of the company’s stock, valued at approximately $1,622,381.62. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Denise Garner sold 25,832 shares of the stock in a transaction on Monday, June 8th. The shares were sold at an average price of $197.62, for a total value of $5,104,919.84. Following the completion of the transaction, the senior vice president now directly owns 17,468 shares of the company’s stock, valued at $3,452,026.16. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 73,011 shares of company stock valued at $14,788,606. Corporate insiders own 1.14% of the company’s stock.
Clorox (NYSE:CLX) last announced its earnings results on Friday, May 1st. The company reported $1.89 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.72 by $0.17. The business had revenue of $1.78 billion during the quarter, compared to the consensus estimate of $1.69 billion. Clorox had a return on equity of 147.52% and a net margin of 13.67%. The business’s quarterly revenue was up 15.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.44 EPS. On average, equities analysts forecast that Clorox Co will post 6.92 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Wednesday, July 29th will be paid a dividend of $1.11 per share. This represents a $4.44 annualized dividend and a dividend yield of 1.88%. This is an increase from Clorox’s previous quarterly dividend of $1.06. The ex-dividend date of this dividend is Tuesday, July 28th. Clorox’s dividend payout ratio is presently 70.25%.
CLX has been the subject of a number of recent analyst reports. Morgan Stanley boosted their target price on shares of Clorox from $177.00 to $193.00 and gave the company an “underweight” rating in a research note on Friday, July 10th. Deutsche Bank lifted their price objective on Clorox from $174.00 to $223.00 and gave the company a “hold” rating in a report on Monday, July 27th. UBS Group lifted their price objective on Clorox from $155.00 to $168.00 and gave the company a “sell” rating in a report on Monday, May 4th. Cfra lifted their price objective on Clorox from $170.00 to $190.00 and gave the company a “hold” rating in a report on Friday, May 1st. Finally, JPMorgan Chase & Co. lifted their price objective on Clorox from $203.00 to $235.00 and gave the company an “overweight” rating in a report on Thursday, July 16th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. Clorox has an average rating of “Hold” and a consensus price target of $185.08.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
See Also: How Does the Quiet Period Work?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.